admin – Page 4514 – Get News Story

Adrenocortical Carcinoma Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Therapies, Treatment, Companies by DelveInsight

“Adrenocortical Carcinoma Treatment Market”

Adrenocortical carcinoma companies such as Enterome, Bristol-Myers Squibb, Cytovation AS, Orphagen Pharmaceuticals, and others.

(Albany, USA) DelveInsight’s Adrenocortical Carcinoma Market Insights report includes a comprehensive understanding of current treatment practices, adrenocortical carcinoma emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into 7MM [the United States, the EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan].

Key Takeaways from the Adrenocortical Carcinoma Market Report

According to DelveInsight’s analysis, the adrenocortical carcinoma market’s total size in the 7MM reached approximately USD 22.4 million in 2023.
As per DelveInsight’s estimations, the total incident cases of adrenocortical carcinoma in the 7MM were approximately 1,200 in 2023 and are projected to increase during the forecast period, owing to the Increasing incidence trends over decades and advancements in diagnostic tools contribute to a better understanding and identification of this rare malignancy.
Leading adrenocortical carcinoma companies such as Enterome, Bristol-Myers Squibb, Cytovation AS, Orphagen Pharmaceuticals, and others are developing novel Adrenocortical Carcinoma drugs that can be available in the adrenocortical carcinoma market in the coming years.
The promising adrenocortical carcinoma therapies in the pipeline include EO2401 + Nivolumab, CyPep-1, and OR-449, among others.
In January 2023, Orphagen Pharmaceuticals announced that the United States Food and Drug Administration (US FDA) has granted a rare pediatric disease designation (RPDD) to OR-449 for treating pediatric ACC.
ADC Therapeutics announced the oral presentation of ADCT-701 at the AACR 2024 conference which was titled as “Targeting DLK1, a Notch ligand, with an antibody-drug conjugate in adrenocortical carcinoma”

Discover which therapies are expected to grab the major adrenocortical carcinoma market share @ Adrenocortical Carcinoma Market Report

Adrenocortical Carcinoma Overview

Adrenocortical carcinoma is a rare but aggressive cancer originating in the adrenal cortex. The cause of adrenocortical carcinoma is largely unknown, though genetic mutations and hereditary conditions are believed to play a role. Risk factors include age, gender differences, and specific genetic tendencies. Symptoms of adrenocortical carcinoma include abdominal pain, unexplained weight loss, hormonal imbalances, and detectable abdominal masses. Due to its rarity and vague symptoms, early detection is often difficult. Adrenocortical carcinoma progresses through four stages. Stages I and II are characterized by localized disease, Stage III involves lymph node involvement, and Stage IV indicates advanced disease with metastasis to distant organs.

Diagnosing adrenocortical carcinoma involves a thorough process beginning with a review of medical history and a physical examination to identify abnormalities in the adrenal gland. Imaging tests such as CT, MRI, and PET scans are used to visualize tumors and assess their spread. Blood and urine tests are conducted to measure hormone levels and metabolic markers. Although biopsies provide a definitive diagnosis, they come with risks and are not always performed. Genetic testing might be recommended, especially if there is a family history of the disease. Staging scans help guide treatment options, which typically include surgery, chemotherapy, radiation, or targeted therapy, all coordinated by multidisciplinary healthcare teams.

Adrenocortical Carcinoma Epidemiology Segmentation

DelveInsight’s analyst forecasts that around 27% of all adrenocortical carcinoma cases in the 7MM originate from the United States. Based on our calculations, the EU4 and the UK together saw ~600 incident cases of adrenocortical carcinoma (ACC) in 2023.

The adrenocortical carcinoma market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

Adrenocortical Carcinoma Incident Cases
Adrenocortical Carcinoma Stage-specific Incident Cases
Adrenocortical Carcinoma Gender-specific Incident Cases
Adrenocortical Carcinoma Age-specific Incident Cases

Adrenocortical Carcinoma Treatment Market

First-line therapies for adrenocortical carcinoma involve a personalized approach tailored to patient-specific prognostic factors. Treatment strategies vary based on these factors, incorporating both local and systemic methods. Patients with good performance status and aggressive disease may undergo combination therapy, such as EDP + M, which includes etoposide, doxorubicin, cisplatin, and mitotane. In contrast, those with less aggressive disease might receive mitotane monotherapy, sometimes supplemented with locoregional therapies.

Despite the effectiveness of EDP-M as a first-line therapy for adrenocortical carcinoma, patient prognosis remains poor. Second-line treatments, such as streptozocin plus mitotane (S+M) and gemcitabine plus capecitabine (G+C), show limited response rates (around 10%). Although G+C is considered modestly effective, it lacks significant predictive molecular markers but generally has tolerable side effects.

Temozolomide used as a third-line chemotherapy for advanced adrenocortical carcinoma, demonstrates anti-tumor activity in vitro. While some clinical studies show disease control in certain patients, its overall efficacy is limited. Ongoing research seeks to define temozolomide’s optimal role, especially in identifying patient subsets that may respond well to treatment.

Future advances in adrenocortical carcinoma treatment may utilize new chemotherapeutic agents, vascular growth inhibitors, and small-molecule therapies, driven by a better understanding of the molecular pathways involved in tumorigenesis. These emerging strategies hold promise for improving therapeutic efficacy and patient outcomes.

Learn more about the FDA-approved drugs for adrenocortical carcinoma @ Drugs for Adrenocortical Carcinoma Treatment

Adrenocortical Carcinoma Pipeline Therapies and Key Companies

The lack of research and development efforts in adrenocortical carcinoma is due to its categorization as an ultra rare disease, indicating a limited pipeline with only a handful of therapies in Phase II, Phase I/II, and preclinical investigations. With only one double combination therapy, “EO2401 + Nivolumab,” showing promise in emerging in the ACC landscape, the field faces considerable challenges. However, this underscores the urgent need for increased investment and focus to propel adrenocortical carcinoma treatment strategies forward.

EO2401, an innovative therapeutic vaccine derived from the microbiome and developed by Enterome, is designed to combat solid tumors such as glioblastoma and adrenocortical carcinoma. By utilizing specific peptides that mimic antigens associated with tumors and triggering immune responses, it seeks to instigate a focused attack by memory T cells against tumor cells. Clinical trials, particularly in cases of glioblastoma, have demonstrated robust immune responses, encouraging efficacy, and a favorable safety profile, especially when combined with checkpoint inhibitors. EO2401 is also exhibiting promise in trials for adrenocortical carcinoma.

Enterome is currently assessing EO2401 in a clinical trial for treating adrenal tumors (SPENCER study, EOADR1-19). In March 2021, Enterome entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb (BMS) to support EO2401, an OncoMimics vaccine in clinical development. Under this agreement, BMS has committed to providing nivolumab at no cost for patients participating in the combined therapy clinical trial SPENCER (EOADR1-19).

CyPep-1 and OR-449 are two promising pharmaceutical candidates currently progressing through clinical development for adrenocortical carcinoma. CyPep-1, a synthetic peptide targeting tumor membranes with 27-D-amino acids in an alpha-helical structure, is being developed by Cytovation AS. It is set to begin Phase II clinical trials in the first half of 2024 as a standalone treatment for adrenocortical carcinoma.

On the other hand, OR-449 from adrenocortical carcinoma is a novel preclinical compound designed as an oral antagonist targeting the orphan nuclear receptor steroidogenic factor-1 (SF-1 or NR5A1). Notably, OR-449 has received a Rare Pediatric Disease Designation (RPDD) from the FDA. Consequently, the company plans to submit an IND application to the FDA later this year, marking the initiation of Phase I clinical trials. These innovative therapies, projected to become available in the therapeutic market between 2024 and 2034, are poised to significantly advance the treatment options for adrenocortical carcinoma.

Discover more about adrenocortical carcinoma market drivers and barriers @ Adrenocortical Carcinoma Market Dynamics

Adrenocortical Carcinoma Market Dynamics

The dynamics of the adrenocortical carcinoma market are expected to change in the coming years. The availability of surgical interventions like adrenalectomy, along with the exclusive approval of Mitotane, consolidating its position as the primary therapeutic option for adrenocortical carcinoma, and the potential of the EO2401 + Nivolumab combination to address immunotherapy resistance, presents a significant opportunity in the scarce therapeutic market of adrenocortical carcinoma, enhancing treatment accessibility and inviting key market players to enter.

Furthermore, many potential therapies are being investigated for the treatment of adrenocortical carcinoma, and it is safe to predict that the treatment space will significantly impact the adrenocortical carcinoma market during the forecast period. Moreover, the anticipated introduction of emerging therapies with improved efficacy and a further improvement in the diagnosis rate are expected to drive the growth of the adrenocortical carcinoma market in the 7MM.

However several factors may impede the growth of the adrenocortical carcinoma market. The limited availability of systemic therapies, coupled with surgery as the primary treatment, poses a weakness due to restricted treatment options for adrenocortical carcinoma, exacerbated by the rarity of the disease, hindering large-scale clinical trials and challenging evidence-based treatment guidelines. Furthermore, resistance or ineffective responses to existing adrenocortical carcinoma treatment options, like mitotane monotherapy, lead to unfavorable patient outcomes, posing a critical challenge, further compounded by the limited availability of funding and resources for research and development due to adrenocortical carcinoma’s ultra-rare status, which poses a significant threat.

Moreover, adrenocortical carcinoma treatment poses a significant economic burden and disrupts patients’ overall well-being and QOL. Furthermore, the adrenocortical carcinoma market growth may be offset by failures and discontinuation of emerging therapies, unaffordable pricing, market access and reimbursement issues, and a shortage of healthcare specialists. In addition, the undiagnosed, unreported cases and the unawareness about the disease may also impact the adrenocortical carcinoma market growth.

Discover more about adrenocortical carcinoma drugs in development @ Adrenocortical Carcinoma Clinical Trials

Scope of the Adrenocortical Carcinoma Market Report

Study Period: 2020–2034
Coverage: 7MM [the United States, the EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan].
Adrenocortical Carcinoma Market CAGR
Adrenocortical Carcinoma Market Size in 2023: USD 22.4 Million
Key Adrenocortical Carcinoma Companies: Enterome, Bristol-Myers Squibb, Cytovation AS, Orphagen Pharmaceuticals, and others
Key Pipeline Adrenocortical Carcinoma Therapies: EO2401 + Nivolumab, CyPep-1, OR-449, and others
Therapeutic Assessment: Adrenocortical Carcinoma current marketed and emerging therapies
Adrenocortical Carcinoma Market Dynamics: Key Market Forecast Assumptions of Emerging Adrenocortical Carcinoma Drugs and Market Outlook
Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
Unmet Needs, KOL’s views, Analyst’s views, Adrenocortical Carcinoma Market Access and Reimbursement

To know more about adrenocortical carcinoma treatment guidelines, visit @ Adrenocortical Carcinoma Management

Table of Contents

1. Key Insights

2. Report Introduction

3. Adrenocortical Carcinoma (ACC) Market Overview at a Glance

4. Epidemiology and Market Forecast Methodology

5. Executive Summary

6. Key Events

7. Disease Background and Overview

8. Epidemiology and Patient Population

9. Patient Journey

10. Marketed Therapies

11. Emerging Therapies

12. Adrenocortical Carcinoma (ACC): Market Analysis

12.1. Key Findings

12.2. Key Market Forecast Assumptions

12.3. Market Outlook

12.4. Total Market Size of ACC in the 7MM

12.5. Market Size of ACC by Therapies in the 7MM

12.6. Market Size of ACC in the United States

12.7. Market Size of ACC in EU4 and the UK

12.8. Market Size of ACC in Japan

13. Key Opinion Leaders’ Views

14. SWOT Analysis

15. Unmet Needs

16. Market Access and Reimbursement

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Adrenocortical Carcinoma Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Therapies, Treatment, Companies by DelveInsight

2024 Asia Digital Art Exhibition Inaugurated

The 2024 Asia Digital Art Exhibition inaugurated on December 19th, 2024 in The China Soong Ching Ling Science & Culture Centre for Young People. This exhibition includes 18 artists from 5 countries and regions, and a total of 15 digital artworks are exhibited.

Abandoned Energy Collection Plan by Ma Shuoli and Li Qiang

Letter From Afar, Fleeting Sculpture, Inverted Calligraphy·Children’s Poetry by Qiu Zhijie

The Asia Digital Art Exhibition aims to provide an interactive platform for the integration of technology and art, and stimulate the audience’s interest and enthusiasm for digital art. This exhibition focuses on artificial intelligence, focusing on interactive devices, AR, games and mechanical devices, and is divided into four major themes: Prologue, Man and Imagination, Man and Nature, and Man and Intelligence.

Thousand-Mile Ink Painting by Ni Shufan

Left: The development log of BugSim by Theo Triantafyllidis

Right: Rebirth of National Rhythms: Poetic Landscape by Gao Feng

During the exhibition, several thematic salons were held, and professionals from different field ‘s were invited to discuss the development and innovation of “AI+ Art”, the application of digital creativity, and the improvement of digital literacy of the people.

Media Contact
Company Name: Beijing Tangying Culture Communication Co.,Ltd
Contact Person: Sun Ying
Email: Send Email
Country: China
Website: www.adae516.com

Why JDA Progress Stands Out: Packaging Equipment Manufacturer Offers Decades of Expertise and Innovation

For over 35 years, JDA Progress Industries has been a trusted name in the packaging equipment industry. As a leading packaging equipment manufacturer, JDA Progress has built its reputation on quality, innovation, and customer-centric solutions tailored to diverse industries such as food & beverage, cosmetics, chemicals, and nutraceuticals.

Located in the north end of Toronto, Ontario, the company’s 15,000-square-foot facility in Vaughan houses an extensive showroom where clients can explore state-of-the-art packaging machinery in action. With an emphasis on providing high-quality equipment such as bottle unscrambler machine, automatic auger fillers, vertical bagger machines, and more, JDA Progress continues to redefine efficiency and reliability in packaging solutions.

Decades of Expertise in Packaging Solutions

Founded in 1988 as a family-owned and operated business, JDA Progress Industries has successfully evolved to meet the changing demands of packaging processes. Over the years, the company has sold thousands of packaging machines across North America and beyond, becoming a go-to resource for businesses looking to optimize their production lines.

“Our mission is to provide solutions that not only meet but exceed our customers’ expectations,” says a representative from JDA Progress. “With over three decades of experience, we’re equipped to handle complex challenges and deliver equipment that supports productivity and growth.”

A Comprehensive Range of Packaging Equipment

JDA Progress is renowned for its diverse portfolio of packaging machines, each designed to cater to specific needs across industries. Key offerings include:

Bottle Unscrambler Machines: JDA’s bottle unscramblers ensure smooth and efficient feeding of bottles into production lines. These machines are ideal for operations that demand high-speed and consistent bottle orientation, improving overall line efficiency.
Automatic Auger Fillers: Perfect for dispensing powders and granular products, automatic auger fillers provide precision and reliability. Whether for food, pharmaceuticals, or chemicals, these machines ensure accurate fills every time.
Automatic Powder Fillers: Designed for speed and accuracy, automatic powder fillers cater to industries requiring bulk and precise powder packaging solutions.
Tube Fillers: For businesses in cosmetics and pharmaceuticals, tube fillers streamline the process of filling and sealing tubes with creams, gels, and ointments. Their versatility makes them a must-have for companies prioritizing quality and consistency.
Vertical Bagger Machines: These machines offer efficient solutions for packaging products in bags. Suitable for various materials, vertical bagger machines are a cornerstone of modern packaging lines.
Conveyor Bottles and Bottling Conveyors: JDA’s bottling conveyors ensure seamless movement of products through the production line, reducing downtime and enhancing productivity.
Vertical Form Fill Seal Machines: These versatile machines combine forming, filling, and sealing into one streamlined process, ideal for high-volume production lines.

Commitment to Innovation

JDA Progress Industries places a strong emphasis on innovation to stay ahead of industry trends. The company continually invests in research and development to enhance the performance, reliability, and efficiency of its equipment. From automated systems like bottle unscrambler machines to advanced tube fillers, JDA’s solutions integrate the latest technologies to meet evolving customer demands.

“Innovation is at the heart of everything we do,” explains the company representative. “We understand that our customers operate in fast-paced environments, so our machines are designed to keep up with their needs while delivering exceptional results.”

Tailored Solutions for Diverse Industries

JDA Progress prides itself on offering customized packaging solutions that address the unique challenges of each industry it serves. Whether it’s an automatic auger filler for a nutraceutical company or a vertical form fill seal machine for a food manufacturer, JDA’s equipment is designed with precision and adaptability in mind.

The company’s long-standing relationships with businesses across food & beverage, cosmetics, chemicals, and nutraceuticals highlight its ability to deliver tailored solutions. By understanding specific industry requirements, JDA Progress ensures that every machine contributes to improved efficiency, reduced waste, and enhanced product quality.

Customer-Centric Approach

At the core of JDA Progress’ success is its unwavering commitment to customer satisfaction. The company’s Vaughan-based showroom serves as a hub where clients can experience live demonstrations and gain hands-on familiarity with equipment such as bottle unscramblers, vertical bagger machines, and conveyor bottles.

“Our goal is to build lasting partnerships with our customers,” notes the company representative. “By offering personalized consultations and reliable after-sales support, we ensure our clients achieve the best results from their investment.”

JDA Progress also maintains a robust inventory of in-stock machines and spare parts, enabling businesses to minimize downtime and keep their production lines running smoothly.

Strategic Location and Global Reach

Situated in Woodbridge, Ontario, JDA Progress Industries benefits from its strategic location near Toronto, Canada’s largest city. This position allows the company to serve local clients efficiently while also reaching international markets. Over the years, JDA’s packaging solutions have been embraced by businesses across North America and beyond, cementing its reputation as a global leader in the industry.

Sustainability and the Future of Packaging

JDA Progress recognizes the growing importance of sustainability in packaging. By designing equipment that minimizes material waste and supports eco-friendly practices, the company helps businesses align with green initiatives.

“Sustainability is not just a trend; it’s a responsibility,” says the representative. “Our machines are engineered to promote efficient use of resources, contributing to a greener future for the packaging industry.”

Experience the JDA Progress Advantage

Whether you’re looking for a bottle unscrambler, a vertical form fill seal machine, or an automatic powder filler, JDA Progress Industries has the expertise and equipment to meet your needs. With a proven track record of innovation, quality, and customer satisfaction, the company continues to lead the way in packaging equipment manufacturing.

For more information or to schedule a showroom visit, contact JDA Progress Industries:

JDA Progress Industries 50 Alex Ave, Unit 1 Woodbridge, ON L4L 5X1, Canada, Phone: 905-850-6434

Media Contact
Company Name: JDA Progress Industries
Contact Person: George
Email: Send Email
Country: Canada
Website: https://www.jdaprogress.com/

A-Z Landscaping: Transforming Outdoor Spaces with Expert Lawn Maintenance Services

A well-maintained lawn is more than just a patch of green; it is a statement of care, beauty, and functionality. For homeowners and businesses alike, creating and maintaining an inviting outdoor space requires expertise, creativity, and attention to detail. A-Z Landscaping, a trusted name in residential and commercial landscaping services, is redefining outdoor spaces with its professional lawn maintenance services and comprehensive landscaping solutions.

A beautifully maintained lawn can elevate the aesthetic appeal and functionality of any property. Whether for a residential or commercial space, achieving this level of perfection requires professional expertise. That’s where A-Z Landscaping excels. Known for its exceptional residential and commercial landscaping services, A-Z Landscaping is redefining outdoor spaces with its top-tier lawn maintenance solutions and comprehensive landscaping expertise.

Excellence in Lawn Maintenance Services

At A-Z Landscaping, the focus is on delivering superior results tailored to every client’s unique needs. Their professional lawn maintenance services cover every aspect required to ensure a lush, healthy, and vibrant lawn year-round. These services include:

Regular Lawn Care: Precision mowing, edging, and trimming for a polished, well-kept look.
Fertilization Programs: Tailored seasonal treatments to enhance lawn health and vitality.
Aeration and Overseeding: Improving soil structure and promoting thicker, greener grass.
Weed and Pest Control: Effective solutions to protect lawns from invasive species and pests.
Irrigation System Installation and Maintenance: Ensuring optimal hydration and water conservation through advanced systems.

These services are meticulously designed to suit lawns of all sizes, ensuring that each client’s outdoor space is both beautiful and functional.

Beyond Lawn Maintenance: Comprehensive Landscaping Solutions

A-Z Landscaping is more than just a lawn maintenance companies. They offer a full range of landscaping solutions to enhance and transform outdoor areas into breathtaking spaces. Their offerings include:

Walkway and Patio Design: Creating visually appealing and durable walkways and patios that complement any property.
Retaining Wall Installation: Functional and stylish solutions to prevent erosion and add structure.
Driveway, Deck, and Pergola Installation: Customized designs that add value and versatility to outdoor areas.
Pool and Outdoor Fireplace Design: Luxury features to elevate outdoor living experiences.
Landscape Lighting: Strategically placed lighting to highlight beauty and improve safety.
Turf Laying and Irrigation Systems: Ensuring a green, healthy lawn with minimal upkeep.

Tailored Designs for Canada’s Unique Climate

Canada’s varied climate offers unique challenges and opportunities for landscaping. A-Z Landscaping’s team of experts specializes in creating designs that thrive under these conditions, from freezing winters to vibrant summers. By incorporating sustainable practices such as drought-resistant plants and efficient irrigation systems, they ensure that their designs remain beautiful and functional throughout the year.

“We take pride in offering solutions that not only meet but exceed our clients’ expectations, regardless of the climate or landscape challenges,” says, Founder and CEO of A-Z Landscaping.

Serving Both Residential and Commercial Clients

A-Z Landscaping caters to a diverse clientele, including homeowners and businesses. For residential clients, the company creates personalized outdoor spaces that reflect their unique style and preferences. Commercial clients benefit from professionally designed landscapes that leave a positive impression on visitors and customers.

Why Choose A-Z Landscaping?

There are numerous landscaping and lawn maintenance companies in the market, but A-Z Landscaping stands out due to its:

Expert Team: Highly trained professionals with years of experience.
Customized Solutions: Tailored services to meet individual client needs.
Focus on Quality: Commitment to delivering outstanding results every time.
Eco-Friendly Practices: Sustainable methods that protect the environment.
Exceptional Customer Service: Dedication to client satisfaction at every stage of the project.

Transforming Outdoor Spaces: Client Success Stories

The impact of A-Z Landscaping’s work can be seen in the glowing testimonials of their satisfied clients. One recent project involved transforming a family’s backyard into a luxurious entertainment area complete with a custom patio, vibrant turf, and strategic lighting. The results exceeded expectations and became the talk of the neighborhood.

Looking to the Future

A-Z Landscaping continues to innovate and expand its services. With plans to grow its service area and introduce cutting-edge landscaping solutions, the company is well-positioned to remain a leader in the industry.

Contact A-Z Landscaping Today

Ready to elevate your outdoor space? The experts at A-Z Landscaping are here to help. Schedule a consultation today to learn how they can bring your vision to life.

Media Contact
Company Name: A-Z Landscaping
Contact Person: George
Email: Send Email
Country: Canada
Website: https://azlandscaping.ca/

BreezeGuard Duct Cleaning Enhances Home Comfort with Expert Air Duct Replacement Services

Enhance indoor air quality and HVAC efficiency with BreezeGuard Duct Cleaning’s expert air duct replacement services in Niles, IL. Call today for a consultation.

BreezeGuard Duct Cleaning offers expert air duct replacement services in Niles, IL, improving air quality, energy efficiency, and HVAC performance for homes and businesses.

Niles, IL – BreezeGuard Duct Cleaning, a trusted leader in air quality solutions, is proud to announce its comprehensive Air Duct Replacement Services for homeowners and businesses in Niles and surrounding areas. With a focus on improving indoor air quality, energy efficiency, and overall HVAC system performance, this service aims to address aging or damaged ductwork that can compromise comfort and health.

Why Air Duct Replacement Matters

Over time, air ducts can accumulate dust, debris, and allergens, or develop leaks that reduce HVAC efficiency and increase energy bills. In some cases, outdated or damaged ductwork may need to be replaced to ensure proper airflow and maintain a clean and healthy environment. BreezeGuard Duct Cleaning specializes in identifying these issues and offering customized solutions to meet the unique needs of each property.

Key Benefits of Air Duct Replacement

Enhanced Air Quality: Replacing old ducts eliminates contaminants that can circulate throughout your home or business.
Energy Efficiency: New ducts improve airflow, reducing strain on HVAC systems and lowering energy consumption.
Cost Savings: Properly sealed and insulated ducts can lead to significant savings on heating and cooling costs.
Comfort Optimization: Balanced airflow ensures consistent temperatures and a more comfortable indoor environment.

Industry Expertise You Can Trust

BreezeGuard’s team of skilled technicians is equipped with the latest tools and technology to provide efficient and seamless air duct replacement services. The company prides itself on delivering top-quality workmanship and exceptional customer service.

“Our mission is to help our clients breathe easier by ensuring their air ducts are functioning optimally,” said a spokesperson for BreezeGuard Duct Cleaning. “With our air duct replacement service, we aim to create healthier, more energy-efficient homes and workplaces.”

For homeowners and businesses experiencing uneven airflow, excessive dust, or rising energy costs, BreezeGuard Duct Cleaning offers free consultations to assess ductwork conditions and provide expert recommendations.

To learn more about BreezeGuard’s air duct replacement services, visit their website at https://breezeguardductcleaning.com/ or call (847) 621-7714 to schedule an appointment.

Media Contact
Company Name: BreezeGuard Duct Cleaning
Contact Person: Haim
Email: Send Email
Phone: (847)621-7714
City: Niles
State: Illinois
Country: United States
Website: https://breezeguardductcleaning.com/

Sriven Info Inc. Targets $500 Million Revenue by 2030, Celebrates 25 Years of Growth

Sriven Info Inc. announces plans to expand its market reach and drive innovation, aiming for $500 million in revenue by 2030 while celebrating 25 years in the technology sector.

Sriven Info Inc. is celebrating its 25th company anniversary with plans to reach $500 million in revenue by 2030, marking a milestone for the IT staffing and services company that now operates in over 35 states.

Founded by IV Reddy in 2000 with an initial investment of $10,000, Sriven Info Inc. has grown into a recognized player in the technology sector. The company credits its growth to a consistent focus on innovation and client satisfaction. Reddy highlighted these principles as key drivers for the company’s next phase.

“Our success over the past 25 years is rooted in our relentless pursuit of innovation and dedication to our clients,” Reddy said. “This foundation will continue to guide us as we expand our market presence and explore new opportunities. By 2030, we believe Sriven Info Inc. will set new benchmarks in the global technology landscape.”

Reddy’s vision for growth is supported by Co-Founder Anil K. Adupa, who joined the company during its early years. Adupa emphasized the collaborative leadership that has propelled the company forward.

“From the moment I joined, I could see the potential in IV’s vision for Sriven Info Inc.,” Adupa said. “Our ability to adapt and drive growth through various market conditions has been key to our success. As we look toward our goal of $500 million in revenue, we are confident in our strategy and the strength of our team.”

Sriven Info Inc.’s growth strategy includes continued leadership in IT staffing and services, along with expansion into emerging technologies through its ZEN G initiative. The program aims to invest in startups and foster innovation in areas critical to the evolving tech landscape.

The company plans to leverage ZEN G to support businesses at the forefront of technological advancements, creating a pipeline for new ideas and solutions that align with industry trends. This initiative reflects Sriven Info Inc.’s broader vision to drive long-term growth while supporting innovation within the tech community.

Reddy pointed to the resilience of the company’s workforce as a cornerstone of its achievements.

“We’ve encountered numerous challenges over the years, but our team’s dedication and ability to adapt have been critical,” Reddy said. “From the dot-com bust to economic downturns and the COVID-19 pandemic, we’ve consistently met our clients’ needs and maintained high standards.”

Over the past 25 years, Sriven Info Inc. has navigated economic shifts and global disruptions by staying true to its core values of integrity, commitment, and client focus. This foundation has allowed the company to expand its reach and services, even during challenging periods.

As part of its future strategy, Sriven Info Inc. is investing in community initiatives and startup ventures, reinforcing its commitment to broader economic growth. By nurturing entrepreneurship and supporting new businesses, the company aims to contribute to a dynamic technology ecosystem.

Adupa underscored the company’s broader mission.

“Our goal isn’t just financial. We’re building a company that delivers value to our clients and employees while also contributing to the communities we operate in,” Adupa said.

The 25th anniversary marks both a celebration of past accomplishments and a springboard for Sriven Info Inc.’s future ambitions. With a focus on sustainable growth and innovation, the company is poised to play an increasingly significant role in the technology sector.

Sriven Info Inc. was founded in 2000 and has grown into a leading IT staffing and services provider with operations in over 35 states. The company offers tailored technology solutions across industries, continuing to expand its footprint through investments in emerging technologies.

The company’s website is available at sriveninfo.ai.

Media Contact
Company Name: Sriven Info Inc
Contact Person: IV Reddy
Email: Send Email
Phone: 4084209387
Address:400 S Oyster Bay Rd,suite: 303A
City: Hicksville
State: NY 11801
Country: United States
Website: https://sriveninfo.ai/

FreshBreeze Air Ducts Introduces Cutting-Edge Air Quality Systems to Elevate Indoor Comfort in Englewood, IL

FreshBreeze Air Ducts delivers innovative air quality systems in Englewood, IL, ensuring cleaner air, balanced humidity, energy efficiency, and healthier indoor spaces for homes and businesses.

FreshBreeze Air Ducts offers advanced air quality systems in Englewood, IL, providing cleaner air, humidity control, energy efficiency, and improved indoor comfort for homes and businesses.

Englewood, IL – FreshBreeze Air Ducts, a trusted name in air quality solutions, is excited to announce the launch of their advanced air quality systems designed to transform indoor spaces in Englewood and surrounding areas. By focusing on cleaner, healthier air, these systems cater to homeowners and businesses looking to enhance their indoor environments with cutting-edge technology and exceptional service.

The Importance of Air Quality Systems

Indoor air pollution is a growing concern, as homes and workplaces can harbor allergens, pollutants, and toxins that affect respiratory health and overall well-being. FreshBreeze Air Ducts’ air quality systems provide a comprehensive solution by addressing issues such as poor ventilation, airborne allergens, and excess humidity.

A representative from FreshBreeze Air Ducts explained, “Indoor air quality impacts every aspect of our lives—from our health to our productivity. Our systems are designed to not only purify air but also create a comfortable and energy-efficient environment.”

Features and Benefits of FreshBreeze Air Quality Systems

Advanced Filtration Technology: Removes up to 99% of airborne particles, including dust, pollen, and pet dander, for cleaner and healthier air.
Humidity Control: Balances moisture levels to reduce the risk of mold growth and improve comfort.
Energy Efficiency: Optimized systems work seamlessly with HVAC units, lowering energy consumption and utility costs.
Customizable Solutions: Tailored designs ensure the perfect fit for homes and businesses of all sizes.
Healthier Living Spaces: Minimized exposure to allergens and pollutants supports better respiratory health and overall wellness.

Comprehensive Services and Support

FreshBreeze Air Ducts offers a full range of services, including system installation, maintenance, and repairs. Their skilled technicians assess each client’s specific needs to recommend and implement solutions that deliver measurable results. In addition to air quality systems, the company also provides air duct cleaning, ensuring a holistic approach to better air.

Commitment to the Englewood Community

FreshBreeze Air Ducts has long been committed to improving the quality of life for Englewood residents. The introduction of their air quality systems reflects their dedication to offering innovative and practical solutions that meet the evolving needs of their customers. By enhancing indoor air, FreshBreeze Air Ducts is helping to create safer, healthier, and more comfortable environments across the community.

FreshBreeze Air Ducts specializes in delivering expert air quality solutions to homes and businesses in Englewood, IL. Their dedication to customer satisfaction and cutting-edge technology has made them a trusted name in the industry.

For more information about FreshBreeze Air Ducts and their air quality systems, visit https://freshbreezeairducts.com/ or call (872) 318-4925.

Media Contact
Company Name: FreshBreeze Air Ducts
Contact Person: Haim
Email: Send Email
Phone: (872) 318-4925
City: Englewood
State: Illinois
Country: United States
Website: https://freshbreezeairducts.com/

Reliant Air Duct Cleaning Oak Park Launches Advanced Dryer Vent Cleaning Services to Enhance Home Safety and Efficiency

Reliant Air Duct Cleaning Oak Park offers expert dryer vent cleaning in Oak Park, IL, ensuring safety, reducing fire risks, enhancing dryer efficiency, and saving energy costs.

Oak Park, IL – Reliant Air Duct Cleaning Oak Park is proud to announce its professional dryer vent cleaning services, designed to safeguard homes from fire risks, improve dryer performance, and promote energy efficiency. Serving residents and businesses in Oak Park and neighboring areas, the company is committed to offering solutions that ensure safety, reliability, and peace of mind.

Addressing Dryer Vent Hazards

Clogged dryer vents are a leading cause of household fires, posing significant risks to property and safety. Over time, lint and debris accumulate in the dryer vent system, restricting airflow and creating a dangerous fire hazard. Reliant Air Duct Cleaning Oak Park employs industry-leading techniques and equipment to remove buildup, significantly reducing the risk of fires and enhancing dryer performance.

A company representative stated, “Our goal is to provide residents of Oak Park with a service that not only protects their homes but also saves them money by improving dryer efficiency. Proper maintenance of dryer vents is a critical aspect of home safety.”

Benefits of Dryer Vent Cleaning

Reliant Air Duct Cleaning Oak Park emphasizes the numerous advantages of routine dryer vent cleaning, including:

Enhanced Safety: Removing lint and debris prevents potential fire hazards caused by clogged vents.
Improved Efficiency: Clean vents reduce drying times, leading to lower energy consumption and utility bills.
Extended Appliance Life: Proper maintenance reduces wear and tear on dryers, prolonging their lifespan.
Healthier Environment: Prevents moisture buildup and reduces the risk of mold and mildew in the vent system.

Professional and Reliable Service

The team at Reliant Air Duct Cleaning Oak Park is composed of trained professionals with extensive experience in vent cleaning. Using cutting-edge tools and techniques, they ensure that every job is performed to the highest standards. The company also offers flexible scheduling to meet the needs of its customers and provide timely service without disruption.

Commitment to the Oak Park Community

Reliant Air Duct Cleaning Oak Park is dedicated to making homes in the community safer and more energy-efficient. Their dryer vent cleaning service complements their air duct cleaning offerings, providing a comprehensive approach to improving indoor air quality and HVAC performance.

Reliant Air Duct Cleaning Oak Park specializes in professional air duct and dryer vent cleaning services. Located at 1033 South Blvd, Oak Park, IL, the company is known for its dedication to quality, customer satisfaction, and safety.

For more information about Reliant Air Duct Cleaning Oak Park and their dryer vent cleaning services, visit their website at https://reliantairductcleaningoakpark.com/ or call (708) 556-2209.

Media Contact
Company Name: Reliant Air Duct Cleaning Oak Park
Contact Person: Haim
Email: Send Email
Phone: (708) 556-2209
Address:1033 South Blvd
City: Oak Park
State: Illinois
Country: United States
Website: https://reliantairductcleaningoakpark.com/

Adeno-Associated Virus Vector in Gene Therapy Market Forecast 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Therapies, Treatment, and Companies by DelveInsight

“Adeno-Associated Virus Vector in Gene Therapy Market”

Adeno-Associated Virus Vectors in Gene Therapy Companies are Biomarin Pharmaceutical, Sarepta Therapeutics, Roche (Spark Therapeutics), Sangamo, Pfizer, NightstaRx, Freeline Therapeutics, Horama S.A, MeiraGTx, RegenxBio, Asklepios Biopharmaceutical, Audentes Therapeutics, and others.

(Albany, USA) DelveInsight’s “Adeno-Associated Virus Vector in Gene Therapy Market Insights, Epidemiology, and Market Forecast–2034” report delivers an in-depth understanding of Adeno-Associated Virus Vector in Gene Therapy, historical and forecasted epidemiology as well as Adeno-Associated Virus Vector in Gene Therapy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Explore the intricate details of the Adeno-Associated Virus Vectors in Gene Therapy Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Adeno-Associated Virus Vectors in Gene Therapy Market Forecast. Click here to stay ahead in healthcare innovation @ Adeno-Associated Virus Vectors in Gene Therapy Market Size

Key Takeaways from the Adeno-Associated Virus Vectors in Gene Therapy Market Report

June 2024:- Aspa Therapeutics- A Phase 1/2 Open-Label Study of the Safety and Clinical Activity of Gene Therapy for Canavan Disease Through Administration of an Adeno-Associated Virus (AAV) Serotype 9-Based Recombinant Vector Encoding the Human ASPA Gene. The main objective of this trial is to evaluate the safety, tolerability, and pharmacodynamic activity of BBP-812, an investigational AAV9-based gene therapy, in pediatric participants with Canavan disease.
June 2024:- Grace Science LLC- A Phase 1/2/3 Open-label, Single Arm, Dose-finding Study to Investigate Long-term Safety, Tolerability and Efficacy of GS-100, an Adeno-associated Virus Serotype 9 (AAV9) Vector-mediated Gene Transfer of Human NGLY1, in Patients With NGLY1 Deficiency. A non-randomized, open-label, dose escalation study of a single intracerebroventricular (ICV) administration of a gene replacement therapy in subjects who are 2 to 18 years old with NGLY1 Deficiency.
Hemophilia A is more common than Hemophilia B, representing approximately 80–85% of the total hemophilia population.
The leading Adeno-Associated Virus Vectors in Gene Therapy Companies such as Biomarin Pharmaceutical, Sarepta Therapeutics, Roche (Spark Therapeutics), Sangamo, Pfizer, NightstaRx, Freeline Therapeutics, Horama S.A, MeiraGTx, RegenxBio, Asklepios Biopharmaceutical, Audentes Therapeutics, and others.
Promising Adeno-Associated Virus Vectors in Gene Therapy Therapies such as BMN 307, AAV9 BBP-812, GS-100, RP-A501, AAV5-hFIXco-Padua, AB-1001 Gene Therapy, and others.

Adeno-Associated Virus Vectors in Gene Therapy Epidemiology Segmentation in the 7MM

Total Prevalent Cases of Selected Indications
Total Diagnosed Prevalent Cases of Selected Indications
Total Treated Cases of Selected Indications

Delve deep into the Adeno-Associated Virus Vectors in Gene Therapy Market Landscape: Analyze drug adoption, treatment paradigms, and epidemiological shifts in our detailed Adeno-Associated Virus Vectors in Gene Therapy Market Forecast. Click here to shape the future @ Adeno-Associated Virus Vectors in Gene Therapy Prevalence

Adeno Associated Virus Vectors in Gene Therapy Marketed Drugs

• LUXTURNA: Spark Therapeutics

LUXTURNA (voretigene neparvovec-rzyl) is a suspension of an adeno-associated virus vector-based gene therapy for subretinal injection. LUXTURNA is a live, non-replicating adeno-associated virus serotype 2 which has been genetically modified to express the human RPE65 gene. LUXTURNA is derived from naturally occurring adeno-associated virus using recombinant DNA techniques. LUXTURNA, is a one-time gene therapy for the treatment of patients with vision loss due to a genetic mutation in both copies of the RPE65 gene. The FDA approved Spark Therapeutics’ LUXTURNA in December 2017.

• ZOLGENSMA: Novartis

ZOLGENSMA is a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. It is a recombinant self-complementary AAV9 containing a transgene encoding the human survival motor neuron (SMN) protein, under the control of a cytomegalovirus enhancer/chicken-β-actin hybrid promoter. ZOLGENSMA an AAV-delivered gene therapy used to treat spinal muscular atrophy (SMA), was approved for clinical use in the US by the FDA.

Navigate the complexities of the Adeno-Associated Virus Vectors in Gene Therapy Market: Gain insights into drug trends, treatment scenarios, and epidemiological data through our insightful Adeno-Associated Virus Vectors in Gene Therapy Market Forecast. Click here to get more insights @ Adeno-Associated Virus Vectors in Gene Therapy Treatment Market

Adeno Associated Virus Vectors in Gene Therapy Emerging Drugs

• LUMEVOQ: GenSight Biologics

LUMEVOQ (GS010; lenadogene nolparvovec) targets Leber Hereditary Optic Neuropathy (LHON) by leveraging a mitochondrial targeting sequence (MTS) proprietary technology platform, arising from research conducted at the Institut de la Vision in Paris, which, when associated with the gene of interest, allows the platform to specifically address defects inside the mitochondria using an AAV vector. According to Phase III results all treated participants showed sustained improvement over 4 years, but that patients treated with a bilateral injection of the gene therapy continued to have a better visual acuity than the patients treated with a unilateral injection, a disparity that had been seen in REFLECT since 1.5 years posttreatment. The company is planning to submit to MHRA in the second half of 2024 and aiming to receive a decision from MHRA on LUMEVOQ in the second half of 2025, in the hopes of commercializing the product in the UK that same year.

• Giroctocogene fitelparvovec: Sangamo and Pfizer

Giroctocogene fitelparvovec comprises of a recombinant AAV6 encoding the complementary deoxyribonucleic acid for B-domain deleted human FVIII. It is being developed as part of a collaboration agreement for the global development and commercialization of gene therapies for hemophilia A between Sangamo and Pfizer. Currently, the company is conducting Phase III trials to attain better and clear results about the efficacy of SB-525. A Phase III clinical trial (NCT03587116) evaluates the effectiveness and safety of preventive replacement therapy in the usual care setting in hemophilia A patients. A pivotal readout is expected in mid-2024, with Pfizer anticipating BLA and MAA submissions in the second half of 2024 if the pivotal readout is supportive.

Unlock insights into the Adeno-Associated Virus Vectors in Gene Therapy Market: discover drug uptake patterns, treatment landscapes, and epidemiological insights with our exclusive Adeno-Associated Virus Vectors in Gene Therapy Market Forecast. Click here @ Adeno-Associated Virus Vectors in Gene Therapy Market Drivers and Barriers

Adeno-Associated Virus Vector in Gene Therapy Market Outlook

Adeno Associated Virus Vectors in Gene Therapy has provided a unique opportunity to treat and even cure degenerative diseases, offering hope to the millions of people either affected by inherited disorders or carrying disease-causing mutations. Addressing optimal intervention timing, standardized outcome assessments, inflammation mitigation, awareness enhancement, and equitable access are key to advancing inherited retinal disease treatments and reshaping the landscape of visual impairment. Gene therapies have brought about a change in the treatment paradigm for genetic diseases by providing lasting therapeutic effects with a single intervention. Gene therapy holds significant potential for addressing various eye diseases. However, individuals considering this treatment should be mindful of certain challenges and crucial factors. Although the recent successes in rare disease therapy approvals have provided momentum for AAV therapy research and funding, several limitations make this a difficult, capital-intensive platform to develop.

Adeno-Associated Virus Vectors in Gene Therapy Drug Market

The report provides insights into therapeutic candidates in Phase III, Phase II/III, and Phase II. It also analyzes key players involved in developing targeted therapeutics. Companies like Sangamo and Pfizer, MEIRAGTx/J&J, Johnson & Johnson, and others actively engage in late and mid-stage research and development efforts for Adeno-Associated Virus Vector in Gene Therapy pipeline possesses potential drugs. However, there is a positive outlook for the therapeutics market, with expectations of growth during the forecast period (2024–2034).

Gain a strategic edge in the Adeno-Associated Virus Vectors in Gene Therapy Market: explore comprehensive drug insights, treatment updates, and epidemiological forecasts in our in-depth Adeno-Associated Virus Vectors in Gene Therapy Market Forecast. Click here to lead in advancements @ Adeno-Associated Virus Vectors in Gene Therapy Clinical Trials Assessment

Scope of the Adeno-Associated Virus Vectors in Gene Therapy Market Report

Coverage- 7MM
Adeno-Associated Virus Vectors in Gene Therapy Companies- Biomarin Pharmaceutical, Sarepta Therapeutics, Roche (Spark Therapeutics), Sangamo, Pfizer, NightstaRx, Freeline Therapeutics, Horama S.A, MeiraGTx, RegenxBio, Asklepios Biopharmaceutical, Audentes Therapeutics, and others.
Adeno-Associated Virus Vectors in Gene Therapy Therapies- BMN 307, AAV9 BBP-812, GS-100, RP-A501, AAV5-hFIXco-Padua, AB-1001 Gene Therapy, and others.
Adeno-Associated Virus Vectors in Gene Therapy Market Dynamics: Adeno-Associated Virus Vectors in Gene Therapy Market Drivers and Barriers
Adeno-Associated Virus Vectors in Gene Therapy Market Access and Reimbursement, Unmet Needs and Future Perspectives

Table of Content

1. Key Insights

2. Report Introduction

3. Key Highlights from Report

4. Executive Summary of AAV in Gene Therapy

5. Key Events

6. Epidemiology and Market Forecast Methodology

7. AAV in Gene Therapy Market Overview at a Glance in the 7MM

8. Disease Background and Overview

9. Epidemiology and Patient Population

10. Marketed Drugs

11. Emerging Drugs

12. AAV in Gene Therapy: 7MM analysis

13. Unmet Needs

14. SWOT Analysis

15. KOL Views

16. Market Access and Reimbursement

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

20. About DelveInsight

About DelveInsight

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Adeno-Associated Virus Vector in Gene Therapy Market Forecast 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Therapies, Treatment, and Companies by DelveInsight

Safe Duct Cleaning Services Revolutionizes Indoor Air Quality with Premier Air Duct Cleaning Solutions in South Salt Lake, UT

Safe Duct Cleaning Services provides top-quality air duct cleaning in South Salt Lake, UT. Improve air quality, energy efficiency, and HVAC performance with expert cleaning solutions.

Safe Duct Cleaning Services offers advanced air duct cleaning in South Salt Lake, UT, enhancing indoor air quality, energy efficiency, and HVAC performance with professional solutions.

South Salt Lake, UT – Safe Duct Cleaning Services is thrilled to introduce its comprehensive and professional air duct cleaning solutions, tailored to meet the growing demand for healthier and more energy-efficient homes and businesses in South Salt Lake and the surrounding communities.

Indoor air quality is a critical component of health and comfort, yet many homeowners overlook the importance of clean air ducts. Over time, dust, allergens, mold, and other contaminants accumulate in ductwork, impacting air quality and putting unnecessary strain on HVAC systems. Safe Duct Cleaning Services is committed to addressing these challenges with their cutting-edge cleaning techniques and customer-first approach.

“At Safe Duct Cleaning Services, we believe everyone deserves to breathe cleaner, healthier air,” said a company representative. “Our expert team is dedicated to removing harmful contaminants from your ductwork, ensuring you enjoy a safer and more efficient living or working environment.”

Key Features of Safe Duct Cleaning Services

Advanced Cleaning Technology: Utilizing the latest equipment, the company thoroughly removes debris, dust, and allergens, ensuring optimal airflow and air quality.
Expert Technicians: Highly trained professionals with extensive experience in air duct cleaning, guaranteeing efficient and effective results.
Energy Efficiency Benefits: Regular cleaning reduces strain on HVAC systems, helping clients save on energy costs while extending the lifespan of their equipment.
Transparent Pricing: Affordable and straightforward pricing with no hidden fees, ensuring customer trust and satisfaction.

The Impact of Clean Air Ducts

Clean air ducts can significantly enhance indoor air quality, benefiting individuals with respiratory conditions, allergies, or sensitivities to airborne particles. Moreover, businesses and homeowners can experience lower utility bills, as clean ducts improve the efficiency of HVAC systems.

Commitment to Customer Satisfaction

Safe Duct Cleaning Services is not just about cleaning ducts; it’s about creating healthier environments and providing peace of mind. The company also offers free consultations and thorough inspections to ensure clients fully understand the benefits of regular air duct maintenance and the value it adds to their property.

Safe Duct Cleaning Services is a trusted name in air duct cleaning, known for its dedication to excellence, customer care, and environmental responsibility. Serving South Salt Lake, UT, and neighboring areas, the company prides itself on delivering top-quality services that prioritize the well-being and satisfaction of its customers.

For more information on how Safe Duct Cleaning Services can improve your indoor air quality, please visit their website at https://safeductcleaningservices.com/ or contact their team at (385) 390-3407.

Media Contact
Company Name: Safe Duct Cleaning Services
Contact Person: Haim Goldstein
Email: Send Email
Phone: (385)390-3407
Address:3821 McCall St E
City: South Salt Lake
State: UT
Country: United States
Website: https://safeductcleaningservices.com/